Washington-Two urology organizations have made good on their promise to fight the Stark II regulations with legal action.
Washington-A sweeping new proposed federal regulation dealing with hospital outpatient compensation would change Medicare payments for specific medical procedures and tighten rules governing new technology payments, a move that could adversely affect urologists. The regulation from the Centers for Medicare & Medicaid Services CMS) would apply to services furnished on or after January 1, 2002.
Minneapolis-American Medical Systems has received FDA approval to market the AMS SPARC Sling System for female stress incontinence. The system's suprapubic approach is designed to provide a potentially safer and simpler option for sling placement, according to the company.
Canton, MA-Organogenesis Inc., has received FDA clearance to market its FortaPerm, a bioengineered surgical sling. The product, which uses the company's FortaFlex engineered collagen technology, is a natural collagen biomaterial indicated for urinary incontinence and vaginal prolapse. It is engineered to add long-term structural support to soft tissue where the patient's tissue is absent or inadequate, according to the company.
As more urologists implement computer technology into their practices, we are learning about the benefits and features of many of the software packages that are available to improve practice efficiency and performance. Unfortunately, those software programs are expensive and require the technological assistance of information technology specialists to load and debug those complicated programs.
Los Angeles-Diagnostic Products Corp., has been granted FDA approval to market four PSA immunoassays for prostate cancer detection: Immulite PSA, Immulite 2000 PSA, Immulite Third Generation PSA, and Immulite 2000 Third Generation PSA. The assays are intended for in vitro diagnostic use with the Immulite and Immulite 2000 immunoassay analyzers.
Reading about the current state of laparoscopic radical prostatectomy related by one of its pioneers may give the impression that this procedure is relatively easy to perform in most patients with prostate cancer (see article, page 1). But it is important to realize that Claude Abbou, MD; Bertrand Guillonneau, MD; Guy Vallencien, MD; and others now have a large clinical experience with the procedure that did not occur overnight. I have been awed by the dedication shown by these French urologists in developing and refining what might be considered the "Mount Everest" of minimally invasive surgery.
The disappearing surplus makes it unlikely that Congress will pass any significant tax cuts, especially tax cuts for businesses, before 2002. Surprisingly, the tax bill passed early in 2001 and "hyped" as being primarily for individual taxpayers, offers relief for many urologists and their practices.
Q. I have heard the term "Modern Portfolio Theory" used in explaining how to balance a portfolio of investments. What is Modern Portfolio Theory?
St. Louis-Mallinckrodt introduces the Liebel-Flarsheim Hydra Vision Plus DR urological imaging system with optional liquid crystal display (LCD) viewing technology. Incorporating the features of the Hydra Vision Plus DR, the new LCD monitor option includes a lightweight triple articulating arm with ergonomic handles for easy movement, according to the company.